We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Samsung

Develops, manufactures, and markets diagnostic products and solutions for IVD and point-of-care applications read more Featured Products: More products

Download Mobile App




Samsung Electronics America Acquires CT Imaging Company

By HospiMedica International staff writers
Posted on 04 Feb 2013
Samsung Electronics America, Inc. More...
(Ridgefield Park, NJ, USA), a subsidiary of Samsung Electronics Co. Ltd. (Gangnam, South Korea), has acquired of NeuroLogica (Danvers, MA, USA), a company that develops computed tomography (CT) systems.

NeuroLogica, established in 2004, develops innovative medical imaging products and is known for its portable CT scanners, such as BodyTom and CereTom. Terms of the deal were not disclosed. The acquisition of NeuroLogica is another critical phase in the expansion of Samsung’s medical imaging business. The company plans to utilize its global brand awareness and advanced technology in international technology (IT) and communications, and consumer electronics, with NeuroLogica to expand medical imaging business.

Samsung Electronics is exploring new avenues of growth in the healthcare business by enhancing medical imaging diagnosis, providing innovation to both patients and physicians.

Samsung Electronics America, Inc. (SEA), markets a wide range of consumer electronics, information systems, and home appliance products, as well as oversees all of Samsung’s North American operations including Samsung Telecommunications America, LLC, Samsung Semiconductor, Inc., Samsung Electronics Canada, Inc. and Samsung Electronics Mexico, Inc. Samsung has become a global leader in consumer electronics and their components with a product range that includes smartphones, televisions, personal computers (PCS), printers, cameras, memory chips, and refrigerators.

NeuroLogica Corp. designs and manufactures imaging equipment that is simple to use and brings the advantages of imaging to the patient. NeuroLogica’s BodyTom CT and CereTom CT are US Food and Drug Administration (FDA)- registered and the quality system is certified to ISO 13485:2003 and ISO 9001:2008 with Canadian Medical Device Amendments. NeuroLogica’s BodyTom CT and CereTom CT are CE marked for distribution in the European Union and European economic area.

Related Links:
Samsung Electronics America
NeuroLogica


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
Isolation Stretcher
IS 736
X-Ray System
Leonardo DR mini III
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.